Dental sealants and composite restorations and longitudinal changes in immune function markers in children

International Journal of Paediatric Dentistry

Volumn 24, Issue 3, 2014, Pages 215-225

  Maserejian, Nancy N ^a,b   Shrader, Peter ^a   Brown, Olivia A ^a   Trachtenberg, Felicia L ^a   Soncini, Jennifer ^c   Hauser, Russ ^d,e   Shenker, Bruce J ^f  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c BOSTON UNIVERSITY   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FISSURE SEALANT; RESIN;

CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; DENTAL RESTORATION; HUMAN; LONGITUDINAL STUDY; RANDOMIZED CONTROLLED TRIAL;

BIOMARKERS; CHILD; COMPOSITE RESINS; DENTAL RESTORATION, PERMANENT; HUMANS; IMMUNITY, CELLULAR; LONGITUDINAL STUDIES; PIT AND FISSURE SEALANTS;

EID: 84897966210     PISSN: 09607439     EISSN: 1365263X     Source Type: Journal    
DOI: 10.1111/ipd.12064     Document Type: Article

References (49)

1. Beltran-Aguilar ED, Barker LK, Canto MT et al. Surveillance for dental caries, dental sealants, tooth retention, edentulism, and enamel fluorosis-United States, 1988-1994 and 1999-2002. MMWR Surveill Summ 2005; 54: 1-43.
2. Beazoglou T, Eklund S, Heffley D, Meiers J, Brown LJ, Bailit H. Economic impact of regulating the use of amalgam restorations. Public Health Rep 2007; 122: 657-663.
3. Bowen RL, inventor. Method of preparing a monomer having phenoxy and methacrylate groups linked by hydroxy glycerol groups. United States 1965 April 20, 1965.
4. Soderholm KJ, Mariotti A. BIS-GMA-based resins in dentistry: are they safe? J Am Dent Assoc 1999; 130: 201-209.
5. Schneider LF, Cavalcante LM, Silikas N. Shrinkage stresses generated during resin-composite applications: a review. J Dent Biomech 2010; 1: 131630.
6. Schweikl H, Spagnuolo G, Schmalz G. Genetic and cellular toxicology of dental resin monomers. J Dent Res 2006; 85: 870-877.
7. Bakopoulou A, Papadopoulos T, Garefis P. Molecular toxicology of substances released from resin-based dental restorative materials. Int J Mol Sci 2009; 10: 3861-3899.
8. Milhem MM, Al-Hiyasat AS, Darmani H. Toxicity testing of restorative dental materials using brine shrimp larvae (Artemia salina). J Appl Oral Sci 2008; 16: 297-301.
9. Schweikl H, Hiller KA, Bolay C et al. Cytotoxic and mutagenic effects of dental composite materials. Biomaterials 2005; 26: 1713-1719.
10. Sletten GB, Dahl JE. Cytotoxic effects of extracts of compomers. Acta Odontol Scand 1999; 57: 316-322.
11. Wataha JC, Rueggeberg FA, Lapp CA et al. In vitro cytotoxicity of resin-containing restorative materials after aging in artificial saliva. Clin Oral Investig 1999; 3: 144-149.
12. Fleisch AF, Sheffield PE, Chinn C, Edelstein BL, Landrigan PJ. Bisphenol A and related compounds in dental materials. Pediatrics 2010; 126: 760-768.
13. Joskow R, Barr DB, Barr JR, Calafat AM, Needham LL, Rubin C. Exposure to bisphenol A from bis-glycidyl dimethacrylate-based dental sealants. J Am Dent Assoc 2006; 137: 353-362.
14. Van Landuyt KL, Nawrot T, Geebelen B et al. How much do resin-based dental materials release? A meta-analytical approach Dent Mater 2011; 27: 723-747.
15. Richter CA, Birnbaum LS, Farabollini F et al. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 2007; 24: 199-224.
16. Ishibashi H, Watanabe N, Matsumura N et al. Toxicity to early life stages and an estrogenic effect of a bisphenol A metabolite, 4-methyl-2, 4-bis(4-hydroxyphenyl)pent-1-ene on the medaka (Oryzias latipes). Life Sci 2005; 77: 2643-2655.
17. Mendiola J, Jorgensen N, Andersson AM et al. Are environmental levels of bisphenol a associated with reproductive function in fertile men? Environ Health Perspect 2010; 118: 1286-1291.
18. Melzer D, Harries L, Cipelli R et al. Bisphenol A exposure is associated with in vivo estrogenic gene expression in adults. Environ Health Perspect 2011; 119: 1788-1793.
19. Melzer D, Gates P, Osborn NJ et al. Urinary bisphenol a concentration and angiography-defined coronary artery stenosis. PLoS One 2012; 7: e43378.
20. Melzer D, Osborne NJ, Henley WE et al. Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation 2012; 125: 1482-1490.
21. Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS. Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS One 2010; 5: e8673.
22. Bhandari R, Xiao J, Shankar A. Urinary bisphenol A and obesity in U.S. children. Am J Epidemiol 2013; 177: 1263-1270.
23. Trasande L, Attina TM, Blustein J. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA 2012; 308: 1113-1121.
24. Wang HX, Zhou Y, Tang CX, Wu JG, Chen Y, Jiang QW. Association between bisphenol A exposure and body mass index in Chinese school children: a cross-sectional study. Environ Health 2012; 11: 79.
25. Wang T, Li M, Chen B et al. Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance. J Clin Endocrinol Metab 2012; 97: E223-E227.
26. Chalubinski M, Kowalski ML. Endocrine disrupters-potential modulators of the immune system and allergic response. Allergy 2006; 61: 1326-1335.
27. Yoshino S, Yamaki K, Yanagisawa R, Takano H, Hayashi H, Mori Y. Effects of bisphenol A on antigen-specific antibody production, proliferative responses of lymphoid cells, and TH1 and TH2 immune responses in mice. Br J Pharmacol 2003; 138: 1271-1276.
28. Yoshino S, Yamaki K, Li X et al. Prenatal exposure to bisphenol A up-regulates immune responses, including T helper 1 and T helper 2 responses, in mice. Immunology 2004; 112: 489-495.
29. Yan H, Takamoto M, Sugane K. Exposure to Bisphenol A prenatally or in adulthood promotes T(H)2 cytokine production associated with reduction of CD4CD25 regulatory T cells. Environ Health Perspect 2008; 116: 514-519.
30. Yurino H, Ishikawa S, Sato T et al. Endocrine disruptors (environmental estrogens) enhance autoantibody production by B1 cells. Toxicol Sci 2004; 81: 139-147.
31. Ohshima Y, Yamada A, Tokuriki S, Yasutomi M, Omata N, Mayumi M. Transmaternal exposure to bisphenol a modulates the development of oral tolerance. Pediatr Res 2007; 62: 60-64.
32. Drozdz K, Wysokinski D, Krupa R, Wozniak K. Bisphenol A-glycidyl methacrylate induces a broad spectrum of DNA damage in human lymphocytes. Arch Toxicol 2011; 85: 1453-1461.
33. Urcan E, Scherthan H, Styllou M, Haertel U, Hickel R, Reichl FX. Induction of DNA double-strand breaks in primary gingival fibroblasts by exposure to dental resin composites. Biomaterials 2010; 31: 2010-2014.
34. Herrstrom P, Bratt I, Holmen A, Hogstedt B. Micronuclei in lymphocyte subsets in relation to plasma mercury, dental amalgam and acrylate-containing tooth fillings. Sci Total Environ 2003; 309: 253-255.
35. Bellinger DC, Trachtenberg F, Barregard L et al. Neuropsychological and renal effects of dental amalgam in children: a randomized clinical trial. JAMA 2006; 295: 1775-1783.
36. Shenker BJ, Maserejian NN, Zhang A, McKinlay S. Immune function effects of dental amalgam in children: a randomized clinical trial. J Am Dent Assoc 2008; 139: 1496-1505.
37. Maserejian NN, Trachtenberg FL, Hauser R et al. Dental composite restorations and psychosocial function in children. Pediatrics 2012; 130: e328-e338.
38. Maserejian NN, Hauser R, Tavares M, Trachtenberg FL, Shrader P, McKinlay S. Dental composites and amalgam and physical development in children. J Dent Res 2012; 91: 1019-1025.
39. Maserejian NN, Trachtenberg FL, Hauser R, McKinlay S, Shrader P, Bellinger DC. Dental composite restorations and neuropsychological development in children: treatment level analysis from a randomized clinical trial. Neurotoxicology 2012; 33: 1291-1297.
40. The Children's Amalgam Trial Study Group. The Children's Amalgam Trial: design and methods. Control Clin Trials 2003; 24: 795-814.
41. Shenker BJ, Rooney C, Vitale L, Shapiro IM. Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes. I. Suppression of T-cell activation. Immunopharmacol Immunotoxicol 1992; 14: 539-553.
42. Shenker BJ, Besack D, McKay T, Pankoski L, Zekavat A, Demuth DR. Induction of cell cycle arrest in lymphocytes by Actinobacillus actinomycetemcomitans cytolethal distending toxin requires three subunits for maximum activity. J Immunol 2005; 174: 2228-2234.
43. InSug O, Datar S, Koch CJ, Shapiro IM, Shenker BJ. Mercuric compounds inhibit human monocyte function by inducing apoptosis: evidence for formation of reactive oxygen species, development of mitochondrial membrane permeability transition and loss of reductive reserve. Toxicology 1997; 124: 211-224.
44. Bayne SC, Thompson JY, Swift EJ Jr, Stamatiades P, Wilkerson M. A characterization of first-generation flowable composites. J Am Dent Assoc 1998; 129: 567-577.
45. Miguez PA, Pereira PN, Foxton RM, Walter R, Nunes MF, Swift EJ Jr. Effects of flowable resin on bond strength and gap formation in Class I restorations. Dent Mater 2004; 20: 839-845.
46. Taylor MR, Holland CV, Spencer R, Jackson JF, O'Connor GI, O'Donnell JR. Haematological reference ranges for schoolchildren. Clin Lab Haematol 1997; 19: 1-15.
47. Shearer WT, Rosenblatt HM, Gelman RS et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 2003; 112: 973-980.
48. Massachusetts Department of Public Health, Bureau of Community Health Access and Promotion. Massachusetts: Burden of Asthma in Massachusetts, 2009.
49. Visness CM, London SJ, Daniels JL et al. Association of childhood obesity with atopic and nonatopic asthma: results from the National Health and Nutrition Examination Survey 1999-2006. J Asthma 2010; 47: 822-829.